You searched for "reinnervation"
Paediatrics
Ray Clarke, Clinical Sub-dean, Alder Hey Hospital, Liverpool, UK. Prof Liat Kishon-Rabin, PhD, Dean of Innovation in Teaching & Learning; Professor of Communication Disorders, Tel Aviv University, Israel; President (2021-2023) of the European Federation of Audiology Societies (EFAS). E: lrabin@tauex.tau.ac.il...Fifteen years of vestibular implant research in humans
Implants: it’s all in the balance! Prof Guyot and his team give us an update on their research in addressing bilateral vestibular deficits via an implant. Doctors are often unaware that people, even young, may lose vestibular function on both...Audiology support for Philippine call centre employees
Call centre employees face unique challenges that impact their hearing health. BPO companies are implementing initiatives in the Philippines to safeguard their auditory wellbeing. The Business Process Outsourcing (BPO) industry in the Philippines is a dynamic and rapidly growing sector....Neural plasticity and aural rehabilitation
Neural plasticity refers to an ability of the brain and central nervous system to change their structure and function or their reorganisation in response to environmental cues, experience, learning, behaviour, injury and / or diseases and treatments. Neural plasticity is...
What is in the Fountain of Youth?
Does the auditory system have to age? Can we become more like turtles or jellyfish and keep our internals running without degradation? This essay considers the theoretical underpinnings of biological processes in the cochlear, in particular the role of the...Entrepreneurial aspirations for the otolaryngologist
Entrepreneurship is a process of identifying an idea and starting a business venture with this idea. It requires generation of a business model or plan that emphasises the value proposition for the customer. The model must identify the partners, resources,...
Polypharmacy in the vestibular clinic
Polypharmacy is defined as the simultaneous use of five or more medications and its prevalence is increasing. Dizziness or vertigo are common side effects of polypharmacy. Despite advancements in patient data management, there remains limited information on polypharmacy in patients...4th Annual Inner Ear Disorders Therapeutics Summit
Terrri Gaskell, Chief Technology Officer, Rinri TherapueticsHeld in Boston, USA, this was an essential gathering that captured the growing excitement in both the biotech and clinical communities surrounding the rapid advancements in hearing loss therapies. With the potential to significantly...Innovating around access to hearing services during the pandemic
COVID-19 has also presented its challenges to hearing healthcare providers and to the industry and, similarly, called for innovation and creativity. Dr Bromwich describes how these sectors are rising to the challenge. The reality of COVID-19 has been a challenging...
